Injection burden Can mix into one syringe or use two Best for Asymmetric dosing or staggered cycling Cycle driver Compound-specific titration CJC-1295 (no DAC) Loading 100 mcg Frequency Once daily Maintenance 200-300 mcg Route SubQ Ipamorelin Loading 100 mcg Frequency Once daily Maintenance 200-300 mcg Route SubQ Weekly Schedule Example Monday CJC-1295 200 mcg + Ipamorelin 200 mcg Tuesday CJC-1295 200 mcg + Ipamorelin 200 mcg Wednesday CJC-1295 200 mcg + Ipamorelin 200 mcg Thursday CJC-1295 200 mcg + Ipamorelin 200 mcg Friday CJC-1295 200 mcg + Ipamorelin 200 mcg Saturday CJC-1295 200 mcg + Ipamorelin 200 mcg Sunday CJC-1295 200 mcg + Ipamorelin 200 mcg When mixing both peptides into a single syringe, draw each peptide separately and combine in the syringe
[PMID: 27581922] PubMed record related to this compound for laboratory literature review
Remember, each woman's experience with menopause is unique, and what works for one may not work for another
Lucena MI, Andrade RJ, de la Cruz JP, Rodriguez-Mendizabal M, Blanco E, Snchez de la Cuesta F
In colorectal cancer, IGF-2 secreted by cancer-associated fibroblasts binds to IGF-1R on cancer cells to activate the PI3K/AKT/mTOR and Hippo-YAP1 signaling pathways to promote cancer cell proliferation, migration and invasion